Print version of this report
TGA Action ID RC-2025-RN-00924-1
Type of Product Medical Device
Product Name/Description Aurora EV-ICD MRI SureScan

Aurora EV-ICD (DVEA3E4), Clinical EV-ICD (DVEX3E4)
ARTG Number 450443
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action In a subset of the above identified devices, there is a potential for delayed time to high-voltage (HV) therapy should a rare sequence of events occur.

A device update via CareLink SmartSync Device manager is available to eliminate this potential delay.

Through 2 October 2025, six (6) events (delay of 2-17 seconds) were observed among approximately 4,900 implanted devices worldwide (0.12%).

Five of the six events experienced this behaviour during a controlled defibrillation threshold test. While not observed clinically, a delay in HV therapy may impact defibrillation efficacy.

The root cause of this behaviour is related to the EV-ICD dynamic sensing algorithm becoming static if a charge-end occurs while the device is processing a sensed event. This will set the sensitivity to 53% of the prior R-wave amplitude. A subsequent R-wave amplitude that exceeds the static 53% level will restore automatic sensitivity operation and allow R-wave synchronisation for therapy delivery.

There have been zero reports of permanent harm or death due to this behaviour.
Instructions for Customers/Users Customers are asked to:

- Ensure their SmartSync application is updated to include the Aurora EV-ICD Application.

- Contact their Medtronic representative if assistance is needed.

- Each patient requires unique clinical considerations. Prophylactic device replacement is NOT recommended.

- Schedule an in-clinic SmartSync interrogation to receive the software update, with the intent for all patients to receive the update within the next 3-6 months.

- Individual devices susceptible to this behaviour can be identified via search/look-up on the Medtronic Product Performance Report Website ( http://productperformance.medtronic.com)

Medtronic has implemented manufacturing changes, and devices manufactured with this update are not susceptible to this delay. In previously distributed devices, a device interrogation with the CareLink SmartSync Aurora EV-ICD application (D00U025) on CareLink SmartSync Device Managers will resolve the potential for this behaviour.

This action has been finalised on 23/01/2026.
Action Commencement Date 29/10/2025
Responsible Entity Medtronic Australasia Pty Ltd
Contact Information 0419 205 911 - Sharon Goodwin